BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712
48 results:

  • 1. A CT-based radiomics nomogram for predicting histologic grade and outcome in chondrosarcoma.
    Li X; Shi X; Wang Y; Pang J; Zhao X; Xu Y; Li Q; Wang N; Duan F; Nie P
    Cancer Imaging; 2024 Apr; 24(1):50. PubMed ID: 38605380
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. u2af1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity.
    Badar T; Vanegas YAM; Nanaa A; Foran JM; Al-Kali A; Mangaonkar A; Murthy H; Alkhateeb HB; Viswanatha D; He R; Shah M; Yi CA; Litzow MR; Gangat N; Tefferi A; Patnaik MM
    Blood Cancer J; 2023 Sep; 13(1):149. PubMed ID: 37735430
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Multimodal imaging-based material mass density estimation for proton therapy using supervised deep learning.
    Chang CW; Marants R; Gao Y; Goette M; Scholey JE; Bradley JD; Liu T; Zhou J; Sudhyadhom A; Yang X
    Br J Radiol; 2023 Dec; 96(1152):20220907. PubMed ID: 37660372
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diagnosis- and Prognosis-Related Gene Alterations in
    Morishita S; Komatsu N
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629188
    [No Abstract]    [Full Text] [Related]  

  • 5. High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis.
    Kanduła Z; Janowski M; Więckowska B; Paczkowska E; Mroczkowska-Bękarciak A; Sobas M; Lewandowski K
    J Appl Genet; 2023 Sep; 64(3):479-491. PubMed ID: 37507589
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical implications of myeloid malignancy‑related somatic mutations in aplastic anemia.
    Liu L; Zhang D; Fu Q; Wang J; Yu J; Chen D; Wang F; Guo R; Xie X; Jiang Z; Li Y
    Clin Exp Med; 2023 Dec; 23(8):4473-4482. PubMed ID: 37087521
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Combinatorial targeting of epigenome-modifying enzymes with decitabine and RN-1 synergistically increases HbF.
    Ibanez V; Vaitkus K; Zhang X; Ramasamy J; Rivers AE; Saunthararajah Y; Molokie R; Lavelle D
    Blood Adv; 2023 Aug; 7(15):3891-3902. PubMed ID: 36884303
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Radon-222 and Leukemia.
    Harley NH; Leslie LA
    Health Phys; 2023 Jun; 124(6):475-477. PubMed ID: 36880974
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Hitting the brakes on accelerated and blast-phase myeloproliferative neoplasms: current and emerging concepts.
    Bewersdorf JP; Rampal RK
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):218-224. PubMed ID: 36485103
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome.
    Kanduła Z; Janowski M; Więckowska B; Paczkowska E; Lewandowski K
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4789-4803. PubMed ID: 36242602
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia.
    Song GY; Kim T; Ahn SY; Jung SH; Kim M; Yang DH; Lee JJ; Choi SH; Kim MY; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Park SK; Kim SH; Zhang Z; Ahn JS; Kim HJ; Kim DDH
    Bone Marrow Transplant; 2022 Dec; 57(12):1810-1819. PubMed ID: 36151367
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Myelofibrosis: Genetic Characteristics and the Emerging Therapeutic Landscape.
    Tefferi A; Gangat N; Pardanani A; Crispino JD
    Cancer Res; 2022 Mar; 82(5):749-763. PubMed ID: 34911786
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Essential thrombocythaemia with aggressive megakaryocytosis after myelofibrotic transformation.
    Sasaki K; Nannya Y; Nakamura Y; Ichikawa M; Ogawa S; Mitani K
    Hematology; 2021 Dec; 26(1):594-600. PubMed ID: 34402416
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Contemporary Practice Patterns for Palliative Radiation Therapy of bone Metastases: Impact of a Quality Improvement Project on Extended Fractionation.
    Jaworski EM; Yin H; Griffith KA; Pandya R; Mancini BR; Jolly S; Boike TP; Moran JM; Dominello MM; Wilson M; Parker J; Burmeister J; Fraser C; Miller L; Baldwin K; Mietzel MA; Grubb M; Kendrick D; Spratt DE; Hayman JA;
    Pract Radiat Oncol; 2021; 11(6):e498-e505. PubMed ID: 34048938
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology.
    Karantanos T; Jain T; Moliterno AR; Jones RJ; DeZern AE
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807519
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Laser interstitial thermotherapy (LITT) for the treatment of tumors of the brain and spine: a brief review.
    Chen C; Lee I; Tatsui C; Elder T; Sloan AE
    J Neurooncol; 2021 Feb; 151(3):429-442. PubMed ID: 33611709
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.
    Bersanelli M; Travaglino E; Meggendorfer M; Matteuzzi T; Sala C; Mosca E; Chiereghin C; Di Nanni N; Gnocchi M; Zampini M; Rossi M; Maggioni G; Termanini A; Angelucci E; Bernardi M; Borin L; Bruno B; Bonifazi F; Santini V; Bacigalupo A; Voso MT; Oliva E; Riva M; Ubezio M; Morabito L; Campagna A; Saitta C; Savevski V; Giampieri E; Remondini D; Passamonti F; Ciceri F; Bolli N; Rambaldi A; Kern W; Kordasti S; Sole F; Palomo L; Sanz G; Santoro A; Platzbecker U; Fenaux P; Milanesi L; Haferlach T; Castellani G; Della Porta MG
    J Clin Oncol; 2021 Apr; 39(11):1223-1233. PubMed ID: 33539200
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [bone marrow fibrosis in primary myelofibrosis in relation to myelodysplasia- and age-related mutations of hematopoietic cells].
    Bartels S; Faisal M; Büsche G; Schlue J; Hasemeier B; Schipper E; Vogtmann J; Westphal L; Lehmann U; Kreipe H
    Pathologe; 2020 Dec; 41(Suppl 2):124-128. PubMed ID: 33113046
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Complex landscape of alternative splicing in myeloid neoplasms.
    Hershberger CE; Moyer DC; Adema V; Kerr CM; Walter W; Hutter S; Meggendorfer M; Baer C; Kern W; Nadarajah N; Twardziok S; Sekeres MA; Haferlach C; Haferlach T; Maciejewski JP; Padgett RA
    Leukemia; 2021 Apr; 35(4):1108-1120. PubMed ID: 32753690
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mutations associated with age-related clonal hematopoiesis in PMF patients with rapid progression to myelofibrosis.
    Bartels S; Faisal M; Büsche G; Schlue J; Hasemeier B; Schipper E; Vogtmann J; Westphal L; Lehmann U; Kreipe H
    Leukemia; 2020 May; 34(5):1364-1372. PubMed ID: 31776465
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.